The Role of Prebiotics and Probiotics as an Adjuvant Therapy in Children with Idiopathic Relapsing Nephrotic Syndrome: A Prospective Open-label Clinical Trial

Idiopathic nephrotic syndrome (INS) is the most common cause of NS in children. It is characterized by the existence of edema, proteinuria, and hypoalbuminemia, as well as repeated relapses. The etiology remains unknown, but new evidence for its pathogenesis relates to the dysfunction of T-regulator...

Full description

Bibliographic Details
Main Authors: Rehab Ahmed Mohammed, Sherin Khamis Hussein, Sylvana Nady Gaber, Ahmed, Fatma Abonaga, Walaa Abdelfattah, Eman Sayed Said, Amy Fakhry Boushra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2022;volume=33;issue=8;spage=169;epage=178;aulast=Mohammed
_version_ 1827779031143022592
author Rehab Ahmed Mohammed
Sherin Khamis Hussein
Sylvana Nady Gaber
Ahmed
Fatma Abonaga
Walaa Abdelfattah
Eman Sayed Said
Amy Fakhry Boushra
author_facet Rehab Ahmed Mohammed
Sherin Khamis Hussein
Sylvana Nady Gaber
Ahmed
Fatma Abonaga
Walaa Abdelfattah
Eman Sayed Said
Amy Fakhry Boushra
author_sort Rehab Ahmed Mohammed
collection DOAJ
description Idiopathic nephrotic syndrome (INS) is the most common cause of NS in children. It is characterized by the existence of edema, proteinuria, and hypoalbuminemia, as well as repeated relapses. The etiology remains unknown, but new evidence for its pathogenesis relates to the dysfunction of T-regulatory (T-reg) cells, which could be caused by dysbiosis of the gut microbiota. Our study aimed to investigate the effect of prebiotics and probiotics as adjuvant therapies for children with relapsing INS. The study was designed as a prospective open-label randomized clinical trial involving 30 children diagnosed with relapsing INS. The children were randomly divided into two groups. Group 1 was treated with prednisone only, and Group 2 was treated with prebiotics and probiotics in addition to prednisone. Fresh stool samples were collected from the children. Lactobacillus species were isolated and identified by conventional microbiological methods. The total number of Lactobacillus species was counted for each stool sample. The population of T-reg cells in the peripheral blood mononuclear cells was analyzed using flow cytometry. Children treated with prebiotics and probiotics in addition to steroids showed a significant increase in T-reg cells (CD4+/CD25+/FOXp3+) in the peripheral blood and a higher count of Lactobacillus species in their stool alongside a significant decrease in the rate of relapses in this group compared with Group 1. Treatment with prebiotics and probiotics signi-ficantly increased T-reg cells and decreased the rate of relapse in INS.
first_indexed 2024-03-11T14:45:25Z
format Article
id doaj.art-796e1602b9cb4cc88967effd36d70b1c
institution Directory Open Access Journal
issn 1319-2442
language English
last_indexed 2024-03-11T14:45:25Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Saudi Journal of Kidney Diseases and Transplantation
spelling doaj.art-796e1602b9cb4cc88967effd36d70b1c2023-10-30T11:57:49ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422022-01-0133816917810.4103/1319-2442.384189The Role of Prebiotics and Probiotics as an Adjuvant Therapy in Children with Idiopathic Relapsing Nephrotic Syndrome: A Prospective Open-label Clinical TrialRehab Ahmed MohammedSherin Khamis HusseinSylvana Nady GaberAhmedFatma AbonagaWalaa AbdelfattahEman Sayed SaidAmy Fakhry BoushraIdiopathic nephrotic syndrome (INS) is the most common cause of NS in children. It is characterized by the existence of edema, proteinuria, and hypoalbuminemia, as well as repeated relapses. The etiology remains unknown, but new evidence for its pathogenesis relates to the dysfunction of T-regulatory (T-reg) cells, which could be caused by dysbiosis of the gut microbiota. Our study aimed to investigate the effect of prebiotics and probiotics as adjuvant therapies for children with relapsing INS. The study was designed as a prospective open-label randomized clinical trial involving 30 children diagnosed with relapsing INS. The children were randomly divided into two groups. Group 1 was treated with prednisone only, and Group 2 was treated with prebiotics and probiotics in addition to prednisone. Fresh stool samples were collected from the children. Lactobacillus species were isolated and identified by conventional microbiological methods. The total number of Lactobacillus species was counted for each stool sample. The population of T-reg cells in the peripheral blood mononuclear cells was analyzed using flow cytometry. Children treated with prebiotics and probiotics in addition to steroids showed a significant increase in T-reg cells (CD4+/CD25+/FOXp3+) in the peripheral blood and a higher count of Lactobacillus species in their stool alongside a significant decrease in the rate of relapses in this group compared with Group 1. Treatment with prebiotics and probiotics signi-ficantly increased T-reg cells and decreased the rate of relapse in INS.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2022;volume=33;issue=8;spage=169;epage=178;aulast=Mohammed
spellingShingle Rehab Ahmed Mohammed
Sherin Khamis Hussein
Sylvana Nady Gaber
Ahmed
Fatma Abonaga
Walaa Abdelfattah
Eman Sayed Said
Amy Fakhry Boushra
The Role of Prebiotics and Probiotics as an Adjuvant Therapy in Children with Idiopathic Relapsing Nephrotic Syndrome: A Prospective Open-label Clinical Trial
Saudi Journal of Kidney Diseases and Transplantation
title The Role of Prebiotics and Probiotics as an Adjuvant Therapy in Children with Idiopathic Relapsing Nephrotic Syndrome: A Prospective Open-label Clinical Trial
title_full The Role of Prebiotics and Probiotics as an Adjuvant Therapy in Children with Idiopathic Relapsing Nephrotic Syndrome: A Prospective Open-label Clinical Trial
title_fullStr The Role of Prebiotics and Probiotics as an Adjuvant Therapy in Children with Idiopathic Relapsing Nephrotic Syndrome: A Prospective Open-label Clinical Trial
title_full_unstemmed The Role of Prebiotics and Probiotics as an Adjuvant Therapy in Children with Idiopathic Relapsing Nephrotic Syndrome: A Prospective Open-label Clinical Trial
title_short The Role of Prebiotics and Probiotics as an Adjuvant Therapy in Children with Idiopathic Relapsing Nephrotic Syndrome: A Prospective Open-label Clinical Trial
title_sort role of prebiotics and probiotics as an adjuvant therapy in children with idiopathic relapsing nephrotic syndrome a prospective open label clinical trial
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2022;volume=33;issue=8;spage=169;epage=178;aulast=Mohammed
work_keys_str_mv AT rehabahmedmohammed theroleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT sherinkhamishussein theroleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT sylvananadygaber theroleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT ahmed theroleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT fatmaabonaga theroleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT walaaabdelfattah theroleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT emansayedsaid theroleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT amyfakhryboushra theroleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT rehabahmedmohammed roleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT sherinkhamishussein roleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT sylvananadygaber roleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT ahmed roleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT fatmaabonaga roleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT walaaabdelfattah roleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT emansayedsaid roleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial
AT amyfakhryboushra roleofprebioticsandprobioticsasanadjuvanttherapyinchildrenwithidiopathicrelapsingnephroticsyndromeaprospectiveopenlabelclinicaltrial